A prescribing governance framework is the point at which an IV service moves beyond a treatment menu and demonstrates accountable clinical practice. It establishes who can prescribe, what information must support a prescribing decision, how medicines are supplied and administered, and what happens when a patient’s presentation does not fit the expected pathway. For patients, this framework is a practical indicator that their care is being assessed rather than assumed.
In the UK, IV therapy may involve prescription-only medicines, fluids, vitamins, minerals and other products with different legal and clinical requirements. The fact that a treatment is familiar, or requested by a patient, does not remove the need for an individual assessment and an appropriate route to supply and administration. Governance provides the structure that makes those decisions clear, reviewable and safe.
What a prescribing governance framework should achieve
A prescribing governance framework is not simply a policy document kept for inspection. It is the operating system for medicines-related care. It should connect clinical assessment, prescribing authority, medicine selection, consent, preparation, administration, monitoring, documentation and follow-up.
Its purpose is to reduce avoidable variation while preserving professional judgement. A clinician needs enough flexibility to decide that IV therapy is unsuitable, to alter a plan where clinically justified, or to refer a patient for further assessment. At the same time, the service needs defined boundaries so that decisions are not based on commercial pressure, incomplete histories or informal assumptions about what is appropriate.
For IV services, this matters particularly because the route of administration can produce effects quickly and may carry risks that require prompt recognition and response. A framework should therefore address the entire patient journey, not only the moment a prescription is written.
Start with lawful prescribing and clear accountability
The framework must identify the legal route under which each medicine is supplied or administered. In many cases, this will be a patient-specific direction following an assessment by an authorised prescriber. Depending on the product and setting, a patient group direction may be appropriate, provided its statutory conditions are met and staff are trained and authorised to work under it. These routes are not interchangeable.
Administration is not prescribing. A practitioner may be competent to cannulate, prepare and administer an infusion, but that does not give them authority to prescribe a prescription-only medicine or to make prescribing decisions outside an agreed legal mechanism. The service should make this distinction explicit in job descriptions, standard operating procedures and training records.
Accountability should also be visible. The responsible clinician, authorised prescribers, medicines lead and operational managers need defined responsibilities, including who reviews incidents, approves protocols and acts on audit findings. Where the service operates in England, governance arrangements should also support relevant Care Quality Commission expectations. Providers elsewhere in the UK should align their systems with the applicable national regulatory requirements.
Define scope before designing protocols
A safe service states what it offers, to whom, and under what circumstances. This includes the products used, intended indications, age limits, clinical exclusions, referral thresholds and settings in which treatment can take place. A broad promise to provide “wellness” infusions is not a clinical scope of practice.
Protocols can support consistency, but they cannot replace assessment. They should set out the information required before treatment, such as medical history, allergies, current medicines, relevant diagnoses, previous reactions and observations where indicated. They should also identify when further investigation, GP liaison or specialist input is needed before proceeding.
The detail required will depend on the intervention. A straightforward hydration plan may require a different assessment from an infusion containing several active ingredients or a treatment for a person with complex co-morbidities. Kidney disease, heart failure, pregnancy, fluid restrictions, electrolyte disturbance and medicines that affect fluid balance are examples of factors that may alter suitability. The framework should make room for these differences rather than applying one checklist to every patient.
Build prescribing decisions around evidence and patient need
Prescribing should have a documented clinical rationale. That rationale need not be lengthy, but it should show why the proposed medicine or fluid is suitable for this individual, what alternatives were considered, and why the expected benefit is proportionate to the potential risk.
For nutrient infusions, a patient’s symptoms alone may not establish a deficiency or demonstrate that intravenous treatment is the appropriate route. Where testing, dietary advice, oral treatment, primary care review or another clinical pathway would be more suitable, the prescriber should say so. This is not a failure of service. It is appropriate stewardship and supports patient trust.
A framework should require prescribers to work within their competence and the limits of their professional registration. It should also set expectations for independent prescribing, supplementary prescribing where relevant, clinical supervision and access to advice. Professional standards from bodies such as the GMC, NMC, GPhC and HCPC remain relevant alongside local clinic policies.
Medicines safety must extend beyond the prescription
Once a prescribing decision is made, medicines governance continues. The service should have controlled arrangements for procurement, receipt, storage, stock rotation, cold-chain monitoring where required, expiry-date checks and disposal. Products should be obtained through legitimate supply routes and held according to the manufacturer’s instructions.
Preparation and administration procedures need to address product checks, dose calculations, compatibility, dilution, labelling, aseptic technique and identity verification. For an IV infusion, the record should make it possible to establish exactly what was administered, in what dose and volume, by whom, when, and with what batch number where applicable.
The framework should also cover adverse reactions and deterioration. Staff need appropriate equipment, current training and clear escalation pathways for complications such as hypersensitivity reactions, vasovagal episodes, infiltration, extravasation, infection concerns or unexpected clinical symptoms. A written emergency protocol is only useful if team members rehearse it and understand their individual role.
Consent, records and continuity of care
Consent for IV therapy is a process rather than a signed form. Patients should receive clear information about the proposed treatment, material risks, realistic expectations, likely alternatives and what to do after leaving the clinic. They should have an opportunity to ask questions and decline without pressure.
Good records support safe continuity of care. They should include the assessment, prescription or applicable direction, consent discussion, administration details, observations where relevant, adverse events, aftercare advice and follow-up plan. Records must be contemporaneous, legible, securely held and accessible to authorised staff.
Where a patient has an existing medical team, communication may be appropriate with their consent, particularly when treatment could affect ongoing care or when new symptoms need investigation. The correct approach depends on the circumstances, confidentiality considerations and the patient’s wishes. A framework should guide clinicians through this judgement rather than requiring automatic disclosure in every case.
Audit turns policy into practice
Policies do not demonstrate quality unless the service checks whether they are followed. A prescribing governance framework should include a proportionate audit programme. This may review the completeness of assessments, legality of supply routes, prescribing rationale, record quality, consent documentation, stock controls, adverse-event reporting and adherence to escalation procedures.
Incidents, near misses and patient feedback should be treated as information for improvement, not merely as administrative tasks. For example, repeated omissions in allergy documentation may indicate that an electronic template needs changing, while variation in dosing may reveal a gap in protocol design or supervision. Trends should be reviewed by the appropriate clinical governance lead, with actions assigned and revisited.
Regular review is particularly necessary when a clinic introduces a new product, changes supplier, revises a protocol or identifies emerging safety information. Version control matters: staff should be able to tell which guidance is current, and retired documents should not remain in circulation.
What patients can reasonably ask a provider
Patients do not need to understand every legal detail, but they can ask direct questions. Who will assess and prescribe the treatment? Is the practitioner appropriately registered and working within their role? What information is needed to decide whether the infusion is suitable? How are medicines sourced, stored and recorded? What happens if they feel unwell during or after treatment?
A reputable provider should welcome these questions and give plain, specific answers. Vague reassurance, pressure to proceed, or reluctance to discuss risks should prompt caution. Clinical governance is most credible when it is visible in the way a service communicates as well as in its internal documents.
For providers, the practical test is straightforward: could an independent clinician follow the patient record and understand why treatment was offered, how it was lawfully authorised, how it was delivered and what safeguards were in place? If not, the framework needs further work.
Thoughtful prescribing governance does not make IV care impersonal. It creates the conditions for clinicians to listen carefully, recognise when treatment is not appropriate and give each patient advice that is safe, transparent and tailored to their circumstances.